SCHEMBL7265697

SCHEMBL7265697

Cc1ccc(-c2ccccc2-c2nnnn2[Sn](C)(C)C)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
TSHR P16473 2/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTGS2 P35354 2/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
HPGD P15428 3/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 1/20 0.38
NPC1 O15118 6/20 0.37
RAB9A P51151 6/20 0.37
MAPT P10636 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KCNN4 O15554 3/20 0.35
LMNA P02545 1/20 0.35
POLB P06746 1/20 0.35
NFKB1 P19838 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7260676 0.85 L3MBTL1 (0.41) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL8539617 0.79 KCNN4 (0.44) ALDH1A1TSHRMEN1KMT2ASMN1; SMN2
SCHEMBL12748014 0.78 AGTR1 (0.46) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL7078741 0.76 PTGS2 (0.31) PTGS2
SCHEMBL13232452 0.75 ALDH1A1 (0.41) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL9571283 0.75 MAOB (0.52)
SCHEMBL7647188 0.74 POLB (0.41) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL8036362 0.72 LMNA (0.50) ALDH1A1TSHRMEN1KMT2APTGS2
SCHEMBL635 0.71 AGTR1 (0.51) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL6360839 0.71 P2RX7 (0.62) ALDH1A1KMT2ANPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003066627-A1 DEUTERATED SPIROCYCLOPENTANIMIDAZOLINONES AND THE USE THEREOF IN THE TREATMENT OF CARDIOVASCULAR DISEASES TURICUM DRUG DEVELOPMENT AG (CH) 2003-08-14 WO disclosed
EP-0643709-A1 4-(1-$i(H)-PYRROL-1-YL)IMIDAZOLES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY WARNER-LAMBERT COMPANY (US) 1995-03-22 EP disclosed
EP-0291969-B1 Tetrazole intermediates to antihypertensive compounds DU PONT (US) 1994-02-16 EP disclosed
US-5276048-A 4-(1H-pyrrol-1-yl)imidazoles with angiotensin II antagonist activity WARNER-LAMBERT COMPANY (US) 1994-01-04 US disclosed
US-5210211-A 4-(1H-PYRROL-1-YL) IMIDAZOLES WITH ANGIOTENSION II ANTAGONIST ACTIVITY WARNER-LAMBERT COMPANY (US) 1993-05-11 US disclosed
WO-1993000341-A1 4-(1-H-PYRROL-1-YL)IMIDAZOLES WITH ANGIOTENSIN II ANTAGONIST ACTIVITY WARNER-LAMBERT COMPANY (US) 1993-01-07 WO disclosed
US-4874867-A Tetrazole intermediates to antihypertensive compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-10-17 US disclosed
US-4870186-A Tetrazole intermediates to antihypertensive compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-09-26 US disclosed
US-4820843-A Tetrazole intermediates to antihypertensive compounds E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-04-11 US disclosed
EP-0291969-A2 Tetrazole intermediates to antihypertensive compounds E.I. DU PONT DE NEMOURS AND COMPANY (US) 1988-11-23 EP disclosed